SystImmune Advances SI-B037 Into Phase 1/1b Trial
Redmond, Washington, U.S., September 22, 2026 SystImmune, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...
FDA IND Clearance
Advertisement
Nona Biosciences Develops AI Model for Human Antibodies
Waltham, Massachusetts, USA, September 17, 2026 Nona Biosciences has announced the successful development of what it describes as the...
SMSbiotech Advances COPD Program With FDA IND Clearance
United States, September 17, 2026 SMSbiotech has announced that the U.S. Food and Drug Administration (FDA) has cleared its...
AbelZeta’s C-CAR168 Receives FDA IND Clearance
San Diego, California, U.S., September 14, 2026 AbelZeta Therapeutics has announced that the U.S. Food and Drug Administration (FDA)...
Harbour BioMed’s WIN378 Shows Positive Phase 2 Asthma Data
Cambridge, Massachusetts, U.S.; Rotterdam, Netherlands; and Shanghai, China, September 8, 2026 Harbour BioMed has announced positive interim results from...
Advertisements
Alebund’s AP308 Gets FDA IND Clearance for IgA Nephropathy
Shanghai, China, September 8, 2026 Alebund Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has cleared...
Ascletis Begins U.S. Phase 1 Study of ASC36
Hong Kong, September 8, 2026 Ascletis Pharma Inc. has announced the initiation of a U.S. Phase 1 clinical trial...
Gilead Wins FDA Approval for Bixlenvo HIV Single Tablet
FOSTER CITY, Calif. – August 27, 2026 Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA)...
Adicet Bio Gains FDA Clearance for ADI-212 IND in mCRPC
REDWOOD CITY, Calif. – August 27, 2026 Adicet Bio, Inc. announced that the U.S. Food and Drug Administration (FDA)...
Kedrion Extends U.S. Agreement to Support GAMMAKED Access
FORT LEE, N.J., August 18, 2026 Kedrion Biopharma announced an extension of its U.S. agreement with Grifols to continue...
Advertisement
